The role of extracellular ATP and P2X receptors in the pathogenesis of HIV-1
- PMID: 36848824
- PMCID: PMC10023410
- DOI: 10.1016/j.coph.2023.102358
The role of extracellular ATP and P2X receptors in the pathogenesis of HIV-1
Abstract
Human Immunodeficiency Virus Type 1 (HIV-1) causes a chronic, incurable infection associated with chronic inflammation despite virologic suppression on antiretroviral therapy (ART). This chronic inflammation underlies significant comorbidities, including cardiovascular disease, neurocognition decline, and malignancies. The mechanisms of chronic inflammation have been attributed, in part, to the role of extracellular ATP and P2X-type purinergic receptors that sense damaged or dying cells and undergo signaling responses to activate inflammation and immunomodulation. This review describes the current literature on the role of extracellular ATP and P2X receptors in HIV-1 pathogenesis, describing the known intersection with the HIV-1 life cycle in mediating immunopathogenesis and neuronal disease. The literature supports key roles for this signaling mechanism in cell-to-cell communication and in activating transcriptional changes that impact the inflammatory state leading to disease progression. Future studies must characterize the numerous functions of ATP and P2X receptors in HIV-1 pathogenesis to inform future therapeutic targeting.
Keywords: Extracellular ATP; HIV-1; Inflammation; P2X receptors; Purinergic receptors.
Copyright © 2023 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Conflict of interest statement Nothing declared.
Figures

Similar articles
-
Purines and purinergic receptors in primary tumors of the central nervous system.Purinergic Signal. 2025 Jun;21(3):429-446. doi: 10.1007/s11302-024-10053-8. Epub 2024 Oct 1. Purinergic Signal. 2025. PMID: 39352574 Free PMC article.
-
Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults.Cochrane Database Syst Rev. 2006 Jul 19;2006(3):CD006148. doi: 10.1002/14651858.CD006148. Cochrane Database Syst Rev. 2006. PMID: 16856117 Free PMC article.
-
Radioligands Targeting the Purinergic P2X Receptors.Cells. 2025 Jun 27;14(13):984. doi: 10.3390/cells14130984. Cells. 2025. PMID: 40643505 Free PMC article. Review.
-
Natural Killer Cell Receptors and Ligands Are Associated With Markers of HIV-1 Persistence in Chronically Infected ART Suppressed Patients.Front Cell Infect Microbiol. 2022 Feb 10;12:757846. doi: 10.3389/fcimb.2022.757846. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35223535 Free PMC article.
-
Purinergic receptors in atherosclerosis: implications for pathophysiology and therapeutic strategies.J Physiol Biochem. 2025 Jul 16. doi: 10.1007/s13105-025-01108-4. Online ahead of print. J Physiol Biochem. 2025. PMID: 40668534 Review.
Cited by
-
Purines and purinergic receptors in primary tumors of the central nervous system.Purinergic Signal. 2025 Jun;21(3):429-446. doi: 10.1007/s11302-024-10053-8. Epub 2024 Oct 1. Purinergic Signal. 2025. PMID: 39352574 Free PMC article.
-
Ca2+ Signaling in Cardiac Fibroblasts: An Emerging Signaling Pathway Driving Fibrotic Remodeling in Cardiac Disorders.Biomedicines. 2025 Mar 17;13(3):734. doi: 10.3390/biomedicines13030734. Biomedicines. 2025. PMID: 40149710 Free PMC article. Review.
-
Self-DNA driven inflammation in COVID-19 and after mRNA-based vaccination: lessons for non-COVID-19 pathologies.Front Immunol. 2024 Feb 19;14:1259879. doi: 10.3389/fimmu.2023.1259879. eCollection 2023. Front Immunol. 2024. PMID: 38439942 Free PMC article.
References
-
- Guaraldi G, Orlando G, Zona S, Menozzi M, Carli F, Garlassi E, Berti A, Rossi E, Roverato A, Palella F. 2011. Premature Age-Related Comorbidities Among HIV-Infected Persons Compared With the General Population. Clinical Infectious Diseases 53:1120–1126. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources